...
首页> 外文期刊>Hepatology research: the official journal of the Japan Society of Hepatology >Immunohistochemical studies on the expression of P-glycoprotein and p53 in relation to histological differentiation and cell proliferation in hepatocellular carcinoma.
【24h】

Immunohistochemical studies on the expression of P-glycoprotein and p53 in relation to histological differentiation and cell proliferation in hepatocellular carcinoma.

机译:肝细胞癌中P-糖蛋白和p53表达与组织分化和细胞增殖相关的免疫组织化学研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Localization of P-glycoprotein (P-gp) and p53 was immunohistochemically examined in 41 patients with hepatocellular carcinoma (HCC) in order to determine the relationship between the expression of P-gp and p53 and the degree of histological differentiation or cell proliferation in HCC. P-gp showed different patterns of expression between cancerous and cirrhotic liver hepatocytes, and the expression in cancerous tissue also varied according to the degree of histological differentiation. In cirrhotic liver hepatocytes, expression of P-gp was found on bile canalicular membranes. In the case of cancerous tissue, P-gp was localized on the canalicular membranes in well-differentiated HCC showing a trabecular pattern, as recognized cirrhotic liver hepatocytes. In moderately differentiated HCC showing pseudo-glandular patterns, predominant expression of P-gp was found on the luminal side of cell membranes of the glandular ducts. The P-gp expression rate was 87.5% in well-differentiated HCC, 84% in moderately differentiated HCC, and 37.5% in poorly differentiated HCC, indicating a marked decrease with decreasing degree of differentiation. On the other hand, the rate of mutation of p53, a tumor suppressor gene, was 12.5% in well-differentiated HCC, 52.0% in moderately differentiated HCC, and 85.5% in poorly differentiated HCC, showing a significant increase with decreasing degree of differentiation (P<0.005). The labeling index (LI) of proliferating cell nuclear antigen (PCNA) tended to increase with the progression of chronic liver disease, with a markedly high value of 24.0+/-1.5% in cases of HCC. The PCNA LI was 15.6+/-11.9% in well-differentiated HCC, 23.1+/-15.1% in moderately differentiated HCC, and 50.1+/-13.3% in poorly differentiated HCC, which indicated a significantly increase in poorly differentiated HCC (P<0.001). Thus, it became apparent that abnormal expressions of P-gp and p53 and the cell proliferation in HCC vary according to the degree of histological differentiation of the malignancy. This suggests that more effective chemotherapy for HCC can be potentially developed by considering the pattern and level of expression of P-gp as a mechanism of drug resistance and the extent of histological differentiation.
机译:为了确定P-gp和p53的表达与HCC的组织学分化程度或细胞增殖程度之间的关系,对41例肝细胞癌(HCC)的患者进行了免疫组化检查P-糖蛋白(P-gp)和p53的定位。 P-gp在癌性和肝硬化性肝肝细胞之间显示出不同的表达模式,并且在癌性组织中的表达也根据组织学分化程度而变化。在肝硬化肝细胞中,在胆管膜上发现了P-gp的表达。在癌性组织中,P-gp定位于分化良好的HCC的小管膜上,表现为小梁型,是公认的肝硬化肝肝细胞。在显示伪腺型的中分化HCC中,P-gp的主要表达位于腺管细胞膜的腔侧。高分化HCC的P-gp表达率为87.5%,中分化HCC为84%,低分化HCC为37.5%,表明随着分化程度的降低明显降低。另一方面,肿瘤抑制基因p53的突变率在高分化HCC中为12.5%,在中分化HCC中为52.0%,在低分化HCC中为85.5%,随着分化程度的降低而显着增加。 (P <0.005)。增殖细胞核抗原(PCNA)的标记指数(LI)倾向于随着慢性肝病的进展而增加,在HCC病例中,其标记值为24.0 +/- 1.5%。高分化HCC的PCNA LI为15.6 +/- 11.9%,中分化HCC为23.1 +/- 15.1%,低分化HCC为50.1 +/- 13.3%,这表明低分化HCC显着增加(P <0.001)。因此,很明显,P-gp和p53的异常表达以及HCC中的细胞增殖根据恶性的组织学分化程度而变化。这表明,通过将P-gp的表达方式和水平作为耐药性机制和组织学分化程度,可以潜在地开发出更有效的HCC化学疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号